UK Care Home Entry And Diversification Will Secure Enduring Potential

Published
02 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$33.50
1.2% overvalued intrinsic discount
14 Aug
US$33.90
Loading
1Y
21.8%
7D
3.0%

Author's Valuation

US$33.5

1.2% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on08 May 25
Fair value Decreased 2.56%

Shared on30 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.35%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget has increased revenue growth from 19.5% to 29.0% and decreased profit margin from 62.4% to 49.6%.

Shared on02 Apr 25
Fair value Increased 9.00%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Increased 0.70%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Increased 1.13%

AnalystConsensusTarget has increased revenue growth from 12.9% to 19.5%, decreased profit margin from 96.6% to 62.4% and increased future PE multiple from 21.3x to 28.1x.

Shared on11 Mar 25
Fair value Decreased 4.07%

AnalystConsensusTarget has decreased revenue growth from 16.0% to 12.9% and decreased future PE multiple from 28.1x to 21.3x.